Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
N. Salord, R. Miralda, A. Farré, M. Carreras, M. Mayos (Barcelona, Spain). Obesity hypoventilation syndrome: efficacy and predictive failure factors for CPAP treatment. Eur Respir J 2008; 32: Suppl. 52, 890

Member's Comments

No comment yet.

Related content which might interest you: Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018 Long-term positive airway pressure therapy in obesity hypoventilation syndrome. Cost study Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 The Pickwick randomized clinical trial: long-term positive airway pressure therapy in obesity hypoventilation syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Cardiovascular comorbidity in obesity hypoventilation syndrome: has nocturnal hypoventilation a protective effect? Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017 Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019 Year: 2020 Long-term echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome? Source: Sleep and Breathing Conference 2021 Year: 2021 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 How to provide NIV in the patient with obesity hypoventilation syndrome Source: Sleep and Breathing Conference 2017 Year: 2017 Long term outcomes of noninvasive positive pressure ventilation for obesity hypoventilation syndrome Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology Year: 2010 Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006 Nocturnal diaphragm failure in obesity hypoventilation syndrome (OHS) Source: Eur Respir J 2004; 24: Suppl. 48, 115s Year: 2004 Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002 Hypoxic challenge assessments in patients with obesity hypoventilation syndrome Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012